- Home
- HLF vs NEO Comparison
HLF vs NEO Comparison
Compare HLF & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLF
- NEO
- Stock Information
- Founded
- HLF 1980
- NEO 2001
- Country
- HLF United States
- NEO United States
- Employees
- HLF N/A
- NEO N/A
- Industry
- HLF Other Pharmaceuticals
- NEO Precision Instruments
- Sector
- HLF Health Care
- NEO Health Care
- Exchange
- HLF Nasdaq
- NEO Nasdaq
- Market Cap
- HLF 854.5M
- NEO 798.3M
- IPO Year
- HLF N/A
- NEO 1999
- Fundamental
- Price
- HLF $9.13
- NEO $7.21
- Analyst Decision
- HLF Strong Buy
- NEO Buy
- Analyst Count
- HLF 4
- NEO 8
- Target Price
- HLF $11.50
- NEO $12.00
- AVG Volume (30 Days)
- HLF 1.9M
- NEO 2.0M
- Earning Date
- HLF 08-06-2025
- NEO 07-29-2025
- Dividend Yield
- HLF N/A
- NEO N/A
- EPS Growth
- HLF 285.96
- NEO N/A
- EPS
- HLF 3.17
- NEO N/A
- Revenue
- HLF $4,928,500,000.00
- NEO $689,189,000.00
- Revenue This Year
- HLF $0.74
- NEO $10.40
- Revenue Next Year
- HLF $4.16
- NEO $10.11
- P/E Ratio
- HLF $2.88
- NEO N/A
- Revenue Growth
- HLF N/A
- NEO 9.70
- 52 Week Low
- HLF $5.04
- NEO $4.72
- 52 Week High
- HLF $10.83
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- HLF 50.78
- NEO 64.64
- Support Level
- HLF $9.15
- NEO $5.94
- Resistance Level
- HLF $9.76
- NEO $6.62
- Average True Range (ATR)
- HLF 0.38
- NEO 0.26
- MACD
- HLF -0.01
- NEO 0.16
- Stochastic Oscillator
- HLF 55.56
- NEO 96.64
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.